Lewis Kriteman, MD
Urology · Roswell, GANPI 1275638488
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $669,656 of the $864,118 with a category attached, or 77.5%. Procept Biorobotics Corporation accounts for 85.6% of it on its own, with 59 other manufacturers making up the rest. Among urology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,240 payments — averaging $696.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$740K
- Boston Scientific$80K
- Strauss Surgical USA LLC$14K
- SRS Medical Systems, Inc.$4K
- Axonics, Inc.$4K
- Neotract Inc.$4K
- plus $19K from 54 others
What the payments were for
- Consulting fees$669,65677%
- Speaking & faculty fees$66,5848%
- Travel & lodging$78,7899%
- Food & beverage$45,7045%
- Education$3,2630%
- Gifts$1230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$550,064
- AQUABEAM SYSTEM$180,239
- GreenLight XPS$31,733
- GREENLIGHT$22,548
- MCB Bipolar Resection Generator and electrode$13,500
- GENERAL BPH$11,691
- CLINICAL TRIAL PRODUCT$4,725
- UroLift$3,687
- UroCuff$3,496
- UroLift System$2,504
- GENERAL - THERAPIES$2,009
- Axonics r-SNM System$1,941
- ProACT$1,809
- TRINITY$1,539
- Bulkamid$1,509
- REZUM$791
- Optilume BPH Drug Coated Balloon Catheter$771
- Axonics$612
- CarePath$473
- CT3000 Pro Base Unit$390
How this compares
$864,118 in reported general payments places this provider in the 95th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 34 | $448,363 |
| ErleadaApalutamide | 21 | $344,724 |
| MyrbetriqMirabegron | 58 | $60,551 |
| GemtesaVibegron | 49 | $46,659 |
| Tamsulosin Hcl | 418 | $6,339 |
| Estradiol | 19 | $3,146 |
| Finasteride | 211 | $2,988 |
| Desmopressin Acetate | 49 | $2,582 |
| Oxybutynin Chloride ErOxybutynin Chloride | 92 | $1,548 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 95 | $1,376 |
| Silodosin | 15 | $1,350 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 103 | $1,141 |
| Testosterone Cypionate | 25 | $1,070 |
| Testosterone | 11 | $978 |
| Solifenacin Succinate | 38 | $836 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $612 | $508,91592 claims |
| Johnson & JohnsonErleada | $219 | $344,72421 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $424 | $46,65949 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 369 urology providers in Georgia.
Other urology in Roswell
- Vahan KassabianRoswell$1.6M
- Scott MillerRoswell$85K
- Akash KapadiaRoswell$63K
- Sophia GoodridgeRoswell$18K
- Daniel BelewRoswell$16K
- Rutveej PatelRoswell$15K
- Daniel CanterDecatur$329K
- Tariq HakkyAtlanta$140K
- Sherita KingAugusta$108K
- Brittani Barrett-HarlowFayetteville$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.